According to MediciNova's latest financial reports the company's current EPS (TTM) is -$0.25. In 2022 the company made an earnings per share (EPS) of -$0.28 a decrease over its 2021 EPS that were of -$0.20.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.25 | -10.71% |
2022 | -$0.28 | 37.29% |
2021 | -$0.20 | -32.02% |
2020 | -$0.30 | 3.45% |
2019 | -$0.29 | -21.62% |
2018 | -$0.37 | 12.12% |
2017 | -$0.33 | -0% |
2016 | -$0.33 | 0% |
2015 | -$0.33 | -15.38% |
2014 | -$0.39 | 95% |
2013 | -$0.20 | -69.7% |
2012 | -$0.66 | -45.9% |
2011 | -$1.22 | -25.15% |
2010 | -$1.63 | -2.98% |
2009 | -$1.68 | -7.18% |
2008 | -$1.81 | -56.59% |
2007 | -$4.17 | 18.47% |
2006 | -$3.52 | 22.22% |
2005 | -$2.88 | -99.54% |
2004 | -$632.26 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Novartis NVS | $3.74 | -1,596.00% | ๐จ๐ญ Switzerland |
Eli Lilly LLY | $5.43 | -2,271.72% | ๐บ๐ธ USA |
Sanofi SNY | $3.18 | -1,372.10% | ๐ซ๐ท France |
Titan Pharmaceuticals
TTNP | -$0.57 | 128.00% | ๐บ๐ธ USA |
Alkermes ALKS | $1.30 | -620.00% | ๐ฎ๐ช Ireland |
Teva Pharmaceutical Industries TEVA | -$2.00 | 700.00% | ๐ฎ๐ฑ Israel |